Transconjunctival Sutureless 25-Gauge Vitrectomy

Phase 3

Completed

• Conditions: Visual Acuity
• Interventions: Procedure: Multifocal IOL implantation + Vitrectomy; Procedure: Multifocal IOL implantation - Vitrectomy

• Registration Number: NCT00870597
• Lead Sponsor: Hospital Oftalmologico de Brasilia

Brief Summary

The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Detailed Description

Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil.

Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy.

Study Timeline

• Study Start: 2007-01
• Primary Completion: 2008-02
• Study Completion: 2008-12
• Status Verified: 2009-03
• Study First Submitted: 2009-03-26
• Study First Submitted QC: 2009-03-26
• Last Update Submitted: 2009-03-26
• Study First Posted: 2009-03-27
• Last Update Posted: 2009-03-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

• disabling vitreous floaters
• Age-related cataract Unsatisfactory correction with glasses

Exclusion Criteria

• central endothelial cell count less than 2000 cells/mm2
• glaucoma or intraocular pressure greater than 21 mmHg
• amblyopia
• retinal abnormalities
• diabetes mellitus
• steroid or immunosuppressive treatment
• connective tissue diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Multifocal IOL implantation + Vitrectomy	Multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed.
2	Multifocal IOL implantation - Vitrectomy	Multifocal IOL implantation without transconjunctival vitrectomy

Primary Outcome Measures

Name	Time	Method
The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation	1 year

Trial Locations

Locations (1)

Hospital Oftalmologico de Brasilia; 🇧🇷 Brasília, DF, Brazil